| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12640-020-00173-5 |
| P698 | PubMed publication ID | 32034697 |
| P2093 | author name string | Jing Chen | |
| Rui Zhang | |||
| Hao Peng | |||
| Jiang He | |||
| Aili Wang | |||
| Yonghong Zhang | |||
| Tan Xu | |||
| Xiaoqing Bu | |||
| Chongke Zhong | |||
| Daoxia Guo | |||
| Chenhuan Zhang | |||
| Ruyi Li | |||
| Sifan Qian | |||
| P2860 | cites work | Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 | Q93084985 |
| Endostatin: an endogenous inhibitor of angiogenesis and tumor growth | Q24315369 | ||
| The first draft of the endostatin interaction network | Q24338820 | ||
| The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment | Q29615678 | ||
| CADASIL and CARASIL. | Q30861866 | ||
| Post-stroke dementia - a comprehensive review | Q31155081 | ||
| Prevalence of post-stroke cognitive impairment in china: a community-based, cross-sectional study | Q35392434 | ||
| Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications. | Q36220259 | ||
| Angiogenesis inhibition and depression in older men | Q37719823 | ||
| Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial | Q38441174 | ||
| Post-stroke depression, obstructive sleep apnea, and cognitive impairment: Rationale for, and barriers to, routine screening | Q38807103 | ||
| Endostatin in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events and survival | Q39618352 | ||
| Increased protein and mRNA expression of endostatin in the ischemic brain tissue of rabbits after middle cerebral artery occlusion | Q40955834 | ||
| VEGF ameliorates cognitive impairment in in vivo and in vitro ischemia via improving neuronal viability and function | Q44194545 | ||
| Association between circulating endostatin, hypertension duration, and hypertensive target-organ damage | Q44207720 | ||
| Angiogenesis in symptomatic intracranial atherosclerosis: predominance of the inhibitor endostatin is related to a greater extent and risk of recurrence. | Q44322045 | ||
| VEGF attenuates 2-VO induced cognitive impairment and neuronal injury associated with the activation of PI3K/Akt and Notch1 pathway | Q47243040 | ||
| Serum Matrix Metalloproteinase-9 and Cognitive Impairment After Acute Ischemic Stroke | Q47558341 | ||
| Therapeutic antibody targeting of Notch3 signaling prevents mural cell loss in CADASIL. | Q48143289 | ||
| Blood Biomarkers for the Early Diagnosis of Stroke: The Stroke-Chip Study | Q48191403 | ||
| Underestimation of cognitive impairment by Mini-Mental State Examination versus the Montreal Cognitive Assessment in patients with transient ischemic attack and stroke: a population-based study | Q48243342 | ||
| Changes in serum vascular endothelial growth factor and endostatin concentrations associated with circulating endothelial progenitor cells after acute ischemic stroke | Q48347982 | ||
| Aberrant neuronal and paracellular deposition of endostatin in brains of patients with Alzheimer's disease. | Q48424633 | ||
| Endostatin level in cerebrospinal fluid of patients with Alzheimer's disease | Q48452946 | ||
| Blood biomarkers in a mouse model of CADASIL. | Q48739198 | ||
| Recommendations for blood pressure measurement in humans: an AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee. | Q51538239 | ||
| A large screening of angiogenesis biomarkers and their association with neurological outcome after ischemic stroke | Q83418836 | ||
| Serum endostatin and risk of mortality in the elderly: findings from 2 community-based cohorts | Q85752861 | ||
| Endothelial Dysfunction Is Associated with Cognitive Impairment of Elderly Cardiovascular Disease Patients | Q91209595 | ||
| Endostatin as a novel prognostic biomarker in acute ischemic stroke | Q91960556 | ||
| Circulating endostatin as a risk factor for cardiovascular events in patients with stable coronary heart disease: A CLARICOR trial sub-study | Q92931838 | ||
| P433 | issue | 4 | |
| P921 | main subject | cognitive dysfunction | Q57859955 |
| P304 | page(s) | 956-964 | |
| P577 | publication date | 2020-02-08 | |
| P1433 | published in | Neurotoxicity Research | Q15764278 |
| P1476 | title | Plasma Endostatin Levels at Acute Phase of Ischemic Stroke Are Associated with Post-Stroke Cognitive Impairment | |
| P478 | volume | 37 |
Search more.